Updates to CORE-008: A phase 2 multi-arm, multi-cohort study to evaluate intravesical cretostimogene grenadenorepvec in patients with high-risk non-muscle invasive bladder cancer.
Authors: Gary D. Steinberg, Trinity Bivalacqua, Siamak Daneshmand, Neal D. Shore, Shreyas Joshi, Colin P.N. Dinney